Modern Healthcare - - Outliers -

“The PR hit is worse than the mon­e­tary hit. The ac­tual busi­ness, as it stands, is not bad. The psy­chol­ogy is bad around th­ese stocks.”

— Les Funt­ley­der, an an­a­lyst for Miller Tabak, in Mar­ketWatch on the ef­fect of the pas­sage of re­form on in­sur­ance com­pany stocks. “The in­flux of newly in­sured rep­re­sents a big, ex­cit­ing op­por­tu­nity for the in­dus­try. … Th­ese 32 mil­lion Amer­i­cans rep­re­sent a con­sid­er­able rise in con­sump­tion of health­care ser­vices, and the leg­is­la­tion is es­pe­cially sig­nif­i­cant with its new lim­its on how much can be spent on ad­min­is­tra­tive costs.”

— Ananda Muk­erji, CEO of First­source So­lu­tions, to Agence France Presse on how out­sourc­ing firms in In­dia could

ben­e­fit from re­form in the U.S.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.